Enhancing Your Research: How GenoBioTX’s Gene Editing Technology Empowers Research Breakthroughs

Registration link:

https://www.eventbrite.com/e/genobiotx-monthly-webinar-tickets-1053785844829

Date:

Wednesday, Oct 30th, 2024; 11:00 am PDT, or 2:00 pm EDT

Webinar Highlights:

This seminar will introduce GenoBioTX’s gene editing platform and technology, highlighting how these techniques can enhance your research projects. We will cover the history of genome editing, provide an overview of GenoBioTX’s gene editing platform and technology, and present case studies that demonstrate how our gene editing techniques can facilitate research advancements.

Meet Our Speaker:

Dr. Yang Yu received his Bachelor of Medicine at Ningxia Medical University in 2014. He continued his education and obtained his Master of Medicine in Nutritional Sciences at Harbin Medical University in 2017. After completed his master’s degree, Yang started his Doctor of Philosophy in Nutritional Sciences at University of Florida in August 2017. After getting his PhD, he joined Dr. Jodie Babitt’s lab at Harvard Medical School/ Mass General Hospital as a postdoctoral fellow. His research focus on gene regulation, transporter function, and mineral metabolism. 

About GenoBioTX

GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.

Contact us

Website: www.genobiotx.com

Email: info@genobiotx.com

Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA

Watch Video
https://youtu.be/Pk2urJQjKjM?si=t9M5oplF4wSBCbBD

    News Center

    2025.04.02

    P53 Mutants, DNA Medicine, and Mobile Genetic Elements

    Register Link: https://www.eventbrite.com/e/genobiotx-april-2025-webinar-tickets-1310558388419?aff=oddtdtcreator Date: Wednesday, April 23rd, 2025; 2:00 pm EDT or 11:00 am PDT Meet Our Speaker: Dr. Li earned his Ph.D. in Molecular Biology in 1999 from the Shanghai Institute of Biochemistry, Chinese Academy of Sciences, followed by postdoctoral training at Yale University (1999–2004). With over 20 years of experience in cancer molecular […]

    2024.11.01

    CCR8: the Next Promising Immune Checkpoint for Antitumor Drugs Development

    CCR8, as a novel immune checkpoint in tumor microenvironment, was hotly discussed during 2022 AACR conference. Since then, numerous prestigious pharmaceutical corporations have shifted their attention to CCR8, previously almost unknown. You may wonder why CCR8 gave rise to so strong interest of pharmaceutical industry. Just follow us to have a quick review of CCR8, […]

    Email Back to top